{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:02:12Z","timestamp":1790283732416,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T00:00:00Z","timestamp":1486684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T00:00:00Z","timestamp":1486684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Abdominal aortic aneurysm (AAA) is a common aortic disease with a progressive nature. There is no approved pharmacological treatment to effectively slow aneurysm growth or prevent rupture. Necroptosis is a form of programmed necrosis that is regulated by receptor-interacting protein kinases (RIPs). We have recently demonstrated that the lack of RIP3 in mice prevented aneurysm formation. The goal of the current study is to test whether perturbing necroptosis affects progression of existing aneurysm using the RIP1 inhibitors Necrostatin-1 (Nec-1) and an optimized form of Nec-1, 7-Cl-O-Nec-1 (Nec-1s). Seven days after aneurysm induction by elastase perfusion, mice were randomly administered DMSO, Nec-1 (3.2\u2009mg\/kg\/day) and Nec-1s (1.6\u2009mg\/kg\/day) via intraperitoneal injection. Upon sacrifice on day 14 postaneurysm induction, the aortic expansion in the Nec-1s group (64.12\u2009\u00b1\u20094.80%) was significantly smaller than that of the DMSO group (172.80\u2009\u00b1\u200913.68%) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The mean aortic diameter of Nec-1 treated mice appeared to be smaller (121.60\u2009\u00b1\u200910.40%) than the DMSO group, though the difference was not statistically significant (<jats:italic>P<\/jats:italic>\u2009=\u20090.1). Histologically, the aortic structure of Nec-1s-treated mice appeared normal, with continuous and organized elastin laminae and abundant \u03b1Actin-expressing SMCs. Moreover, Nect-1s treatment diminished macrophage infiltration and MMP9 accumulation and increased aortic levels of tropoelastin and lysyl oxidase. Together, our data suggest that pharmacological inhibition of necroptosis with Nec-1s stabilizes pre-existing aneurysms by diminishing inflammation and promoting connective tissue repair.<\/jats:p>","DOI":"10.1038\/srep42159","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T12:52:27Z","timestamp":1486731147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Inhibition of Receptor-Interacting Protein Kinase 1 with Necrostatin\u20131s ameliorates disease progression in elastase-induced mouse abdominal aortic aneurysm model"],"prefix":"10.1038","volume":"7","author":[{"given":"Qiwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"Assa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Craig","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,10]]},"reference":[{"key":"BFsrep42159_CR1","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.107.735274","volume":"117","author":"BT Baxter","year":"2008","unstructured":"Baxter, B. T., Terrin, M. C. & Dalman, R. L. Medical management of small abdominal aortic aneurysms. Circulation 117, 1883\u20131889 (2008).","journal-title":"Circulation"},{"key":"BFsrep42159_CR2","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMcibr0905244","volume":"361","author":"NL Weintraub","year":"2009","unstructured":"Weintraub, N. L. Understanding abdominal aortic aneurysm. The New England journal of medicine 361, 1114\u20131116 (2009).","journal-title":"The New England journal of medicine"},{"key":"BFsrep42159_CR3","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJMcp012641","volume":"348","author":"JT Powell","year":"2003","unstructured":"Powell, J. T. & Greenhalgh, R. M. Clinical practice. Small abdominal aortic aneurysms. The New England journal of medicine 348, 1895\u20131901 (2003).","journal-title":"The New England journal of medicine"},{"key":"BFsrep42159_CR4","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1056\/NEJMcp1401430","volume":"371","author":"KC Kent","year":"2014","unstructured":"Kent, K. C. Clinical practice. Abdominal aortic aneurysms. The New England journal of medicine 371, 2101\u20132108 (2014).","journal-title":"The New England journal of medicine"},{"key":"BFsrep42159_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.7326\/0003-4819-126-6-199703150-00004","volume":"126","author":"FA Lederle","year":"1997","unstructured":"Lederle, F. A. et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Annals of internal medicine 126, 441\u2013449 (1997).","journal-title":"Annals of internal medicine"},{"key":"BFsrep42159_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1161\/01.CIR.0000133279.07468.9F","volume":"110","author":"AR Brady","year":"2004","unstructured":"Brady, A. R. et al. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 110, 16\u201321 (2004).","journal-title":"Circulation"},{"key":"BFsrep42159_CR7","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1161\/CIRCULATIONAHA.108.806505","volume":"119","author":"JH Lindeman","year":"2009","unstructured":"Lindeman, J. H., Abdul-Hussien, H., van Bockel, J. H., Wolterbeek, R. & Kleemann, R. Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation 119, 2209\u20132216 (2009).","journal-title":"Circulation"},{"key":"BFsrep42159_CR8","doi-asserted-by":"publisher","first-page":"815","DOI":"10.7326\/0003-4819-159-12-201312170-00007","volume":"159","author":"CA Meijer","year":"2013","unstructured":"Meijer, C. A. et al. Doxycycline for stabilization of abdominal aortic aneurysms: a randomized trial. Annals of internal medicine 159, 815\u2013823 (2013).","journal-title":"Annals of internal medicine"},{"key":"BFsrep42159_CR9","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.4049\/jimmunol.0803164","volume":"183","author":"W Xiong","year":"2009","unstructured":"Xiong, W. et al. Blocking TNF-alpha attenuates aneurysm formation in a murine model. Journal of immunology 183, 2741\u20132746 (2009).","journal-title":"Journal of immunology"},{"key":"BFsrep42159_CR10","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1161\/01.ATV.0000143384.69170.2d","volume":"24","author":"M Ishibashi","year":"2004","unstructured":"Ishibashi, M. et al. Bone Marrow-Derived Monocyte Chemoattractant Protein-1 Receptor CCR2 Is Critical in Angiotensin II-Induced Acceleration of Atherosclerosis and Aneurysm Formation in Hypercholesterolemic Mice. Arterioscler Thromb Vasc Biol 24, e174\u2013178 (2004).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFsrep42159_CR11","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1172\/JCI31311","volume":"117","author":"J Sun","year":"2007","unstructured":"Sun, J. et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest 117, 3359\u20133368 (2007).","journal-title":"J Clin Invest"},{"key":"BFsrep42159_CR12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/ATVBAHA.112.300432","volume":"33","author":"WF Johnston","year":"2013","unstructured":"Johnston, W. F. et al. Genetic and pharmacologic disruption of interleukin-1beta signaling inhibits experimental aortic aneurysm formation. Arteriosclerosis, thrombosis, and vascular biology 33, 294\u2013304 (2013).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"BFsrep42159_CR13","doi-asserted-by":"publisher","first-page":"9013","DOI":"10.1074\/jbc.M113.515957","volume":"289","author":"J Ren","year":"2014","unstructured":"Ren, J. et al. Protein kinase C-delta (PKCdelta) regulates proinflammatory chemokine expression through cytosolic interaction with the NF-kappaB subunit p65 in vascular smooth muscle cells. The Journal of biological chemistry 289, 9013\u20139026 (2014).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep42159_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1124\/jpet.115.227934","volume":"356","author":"J Ren","year":"2016","unstructured":"Ren, J. et al. Andrographolide Ameliorates Abdominal Aortic Aneurysm Progression by Inhibiting Inflammatory Cell Infiltration through Downregulation of Cytokine and Integrin Expression. J Pharmacol Exp Ther 356, 137\u2013147 (2016).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep42159_CR15","first-page":"993","volume":"150","author":"A Lopez-Candales","year":"1997","unstructured":"Lopez-Candales, A. et al. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol 150, 993\u20131007 (1997).","journal-title":"Am J Pathol"},{"key":"BFsrep42159_CR16","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1161\/ATVBAHA.112.255661","volume":"32","author":"S Morgan","year":"2012","unstructured":"Morgan, S. et al. Elevated protein kinase C-delta contributes to aneurysm pathogenesis through stimulation of apoptosis and inflammatory signaling. Arteriosclerosis, thrombosis, and vascular biology 32, 2493\u20132502 (2012).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"BFsrep42159_CR17","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1161\/ATVBAHA.109.200527","volume":"30","author":"D Yamanouchi","year":"2010","unstructured":"Yamanouchi, D. et al. Effects of caspase inhibitor on angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice. Arteriosclerosis, thrombosis, and vascular biology 30, 702\u2013707 (2010).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"BFsrep42159_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/01.CIR.99.1.96","volume":"99","author":"EL Henderson","year":"1999","unstructured":"Henderson, E. L. et al. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 99, 96\u2013104 (1999).","journal-title":"Circulation"},{"key":"BFsrep42159_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1196\/annals.1383.029","volume":"1085","author":"RW Thompson","year":"2006","unstructured":"Thompson, R. W. et al. Pathophysiology of abdominal aortic aneurysms: insights from the elastase-induced model in mice with different genetic backgrounds. Annals of the New York Academy of Sciences 1085, 59\u201373 (2006).","journal-title":"Annals of the New York Academy of Sciences"},{"key":"BFsrep42159_CR20","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1161\/CIRCRESAHA.116.304899","volume":"116","author":"Q Wang","year":"2015","unstructured":"Wang, Q. et al. Receptor-interacting protein kinase 3 contributes to abdominal aortic aneurysms via smooth muscle cell necrosis and inflammation. Circulation research 116, 600\u2013611 (2015).","journal-title":"Circulation research"},{"key":"BFsrep42159_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev, A. et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4, 313\u2013321 (2008).","journal-title":"Nat Chem Biol"},{"key":"BFsrep42159_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMra1310050","volume":"370","author":"A Linkermann","year":"2014","unstructured":"Linkermann, A. & Green, D. R. Necroptosis. The New England journal of medicine 370, 455\u2013465 (2014).","journal-title":"The New England journal of medicine"},{"key":"BFsrep42159_CR23","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","volume":"137","author":"YS Cho","year":"2009","unstructured":"Cho, Y. S. et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112\u20131123 (2009).","journal-title":"Cell"},{"key":"BFsrep42159_CR24","doi-asserted-by":"publisher","first-page":"31268","DOI":"10.1074\/jbc.M113.462341","volume":"288","author":"WJ Kaiser","year":"2013","unstructured":"Kaiser, W. J. et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. The Journal of biological chemistry 288, 31268\u201331279 (2013).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep42159_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.molcel.2014.10.021","volume":"56","author":"P Mandal","year":"2014","unstructured":"Mandal, P. et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell 56, 481\u2013495 (2014).","journal-title":"Mol Cell"},{"key":"BFsrep42159_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrm3683","volume":"14","author":"D Ofengeim","year":"2013","unstructured":"Ofengeim, D. & Yuan, J. Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nature reviews. Molecular cell biology 14, 727\u2013736 (2013).","journal-title":"Nature reviews. Molecular cell biology"},{"key":"BFsrep42159_CR27","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1128\/MCB.24.4.1464-1469.2004","volume":"24","author":"K Newton","year":"2004","unstructured":"Newton, K., Sun, X. & Dixit, V. M. Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol 24, 1464\u20131469 (2004).","journal-title":"Mol Cell Biol"},{"key":"BFsrep42159_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1074-7613(00)80535-X","volume":"8","author":"MA Kelliher","year":"1998","unstructured":"Kelliher, M. A. et al. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8, 297\u2013303 (1998).","journal-title":"Immunity"},{"key":"BFsrep42159_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev, A. et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1, 112\u2013119 (2005).","journal-title":"Nat Chem Biol"},{"key":"BFsrep42159_CR30","doi-asserted-by":"publisher","first-page":"21695","DOI":"10.1073\/pnas.1009179107","volume":"107","author":"G Trichonas","year":"2010","unstructured":"Trichonas, G. et al. Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc Natl Acad Sci USA 107, 21695\u201321700 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep42159_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00540-013-1716-3","volume":"28","author":"S Koshinuma","year":"2014","unstructured":"Koshinuma, S., Miyamae, M., Kaneda, K., Kotani, J. & Figueredo, V. M. Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury. Journal of anesthesia 28, 235\u2013241 (2014).","journal-title":"Journal of anesthesia"},{"key":"BFsrep42159_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/01.ATV.0000118013.72016.ea","volume":"24","author":"A Daugherty","year":"2004","unstructured":"Daugherty, A. & Cassis, L. A. Mouse models of abdominal aortic aneurysms. Arteriosclerosis, thrombosis, and vascular biology 24, 429\u2013434 (2004).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"BFsrep42159_CR33","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/sj.cdd.4401250","volume":"10","author":"I Unal Cevik","year":"2003","unstructured":"Unal Cevik, I. & Dalkara, T. Intravenously administered propidium iodide labels necrotic cells in the intact mouse brain after injury. Cell death and differentiation 10, 928\u2013929 (2003).","journal-title":"Cell death and differentiation"},{"key":"BFsrep42159_CR34","doi-asserted-by":"publisher","first-page":"e92053","DOI":"10.1371\/journal.pone.0092053","volume":"9","author":"Q Wang","year":"2014","unstructured":"Wang, Q. et al. Monocyte chemoattractant protein-1 (MCP-1) regulates macrophage cytotoxicity in abdominal aortic aneurysm. PloS one 9, e92053 (2014).","journal-title":"PloS one"},{"key":"BFsrep42159_CR35","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jtcvs.2009.07.075","volume":"138","author":"G Ailawadi","year":"2009","unstructured":"Ailawadi, G. et al. Smooth muscle phenotypic modulation is an early event in aortic aneurysms. The Journal of thoracic and cardiovascular surgery 138, 1392\u20131399 (2009).","journal-title":"The Journal of thoracic and cardiovascular surgery"},{"key":"BFsrep42159_CR36","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/ATVBAHA.112.300663","volume":"33","author":"L Boytard","year":"2013","unstructured":"Boytard, L. et al. Role of proinflammatory CD68(+) mannose receptor(\u2212) macrophages in peroxiredoxin-1 expression and in abdominal aortic aneurysms in humans. Arteriosclerosis, thrombosis, and vascular biology 33, 431\u2013438 (2013).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"BFsrep42159_CR37","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.ajpath.2011.05.049","volume":"179","author":"DL Rateri","year":"2011","unstructured":"Rateri, D. L. et al. Prolonged infusion of angiotensin II in apoE(\u2212\/\u2212) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am J Pathol 179, 1542\u20131548 (2011).","journal-title":"Am J Pathol"},{"key":"BFsrep42159_CR38","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1172\/JCI8931","volume":"105","author":"R Pyo","year":"2000","unstructured":"Pyo, R. et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. The Journal of clinical investigation 105, 1641\u20131649 (2000).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep42159_CR39","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/nm1335","volume":"11","author":"K Yoshimura","year":"2005","unstructured":"Yoshimura, K. et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nature medicine 11, 1330\u20131338 (2005).","journal-title":"Nature medicine"},{"key":"BFsrep42159_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1067\/msy.2000.107379","volume":"128","author":"MD Huffman","year":"2000","unstructured":"Huffman, M. D. et al. Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms. Surgery 128, 429\u2013438 (2000).","journal-title":"Surgery"},{"key":"BFsrep42159_CR41","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1161\/ATVBAHA.111.239954","volume":"31","author":"MR Bennett","year":"2011","unstructured":"Bennett, M. R. Cell death in cardiovascular disease. Arterioscler Thromb Vasc Biol 31, 2779\u20132780 (2011).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFsrep42159_CR42","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/cvr\/cvu146","volume":"103","author":"M Luedde","year":"2014","unstructured":"Luedde, M. et al. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovascular research 103, 206\u2013216 (2014).","journal-title":"Cardiovascular research"},{"key":"BFsrep42159_CR43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.celrep.2012.12.012","volume":"3","author":"J Lin","year":"2013","unstructured":"Lin, J. et al. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep 3, 200\u2013210 (2013).","journal-title":"Cell Rep"},{"key":"BFsrep42159_CR44","doi-asserted-by":"publisher","first-page":"11007","DOI":"10.1073\/pnas.1514730112","volume":"112","author":"L Meng","year":"2015","unstructured":"Meng, L., Jin, W. & Wang, X. RIP3-mediated necrotic cell death accelerates systematic inflammation and mortality. Proceedings of the National Academy of Sciences of the United States of America 112, 11007\u201311012 (2015).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep42159_CR45","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","volume":"137","author":"S He","year":"2009","unstructured":"He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137, 1100\u20131111 (2009).","journal-title":"Cell"},{"key":"BFsrep42159_CR46","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.1172308","volume":"325","author":"DW Zhang","year":"2009","unstructured":"Zhang, D. W. et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332\u2013336 (2009).","journal-title":"Science"},{"key":"BFsrep42159_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213\u2013227 (2012).","journal-title":"Cell"},{"key":"BFsrep42159_CR48","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrm2970","volume":"11","author":"P Vandenabeele","year":"2010","unstructured":"Vandenabeele, P., Galluzzi, L., Vanden Berghe, T. & Kroemer, G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11, 700\u2013714 (2010).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFsrep42159_CR49","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1038\/onc.2012.337","volume":"32","author":"BA Abhari","year":"2013","unstructured":"Abhari, B. A. et al. RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1\/FADD\/caspase-8 cell death complex. Oncogene 32, 3263\u20133273 (2013).","journal-title":"Oncogene"},{"key":"BFsrep42159_CR50","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1161\/CIRCULATIONAHA.114.011195","volume":"130","author":"L Li","year":"2014","unstructured":"Li, L. et al. Transforming growth factor beta-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling. Circulation 130, 2162\u20132172 (2014).","journal-title":"Circulation"},{"key":"BFsrep42159_CR51","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.26200","volume":"57","author":"S Roychowdhury","year":"2013","unstructured":"Roychowdhury, S., McMullen, M. R., Pisano, S. G., Liu, X. & Nagy, L. E. Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 57, 1773\u20131783 (2013).","journal-title":"Hepatology"},{"key":"BFsrep42159_CR52","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.4017","volume":"22","author":"T Zhang","year":"2016","unstructured":"Zhang, T. et al. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nature medicine 22, 175\u2013182 (2016).","journal-title":"Nature medicine"},{"key":"BFsrep42159_CR53","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nchembio0313-192a","volume":"9","author":"A Degterev","year":"2013","unstructured":"Degterev, A. et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 9, 192\u2013192 (2013).","journal-title":"Nat Chem Biol"},{"key":"BFsrep42159_CR54","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.4049\/jimmunol.1400590","volume":"193","author":"A Polykratis","year":"2014","unstructured":"Polykratis, A. et al. Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo . J Immunol 193, 1539\u20131543 (2014).","journal-title":"J Immunol"},{"key":"BFsrep42159_CR55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","volume":"38","author":"A Kaczmarek","year":"2013","unstructured":"Kaczmarek, A., Vandenabeele, P. & Krysko, D. V. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38, 209\u2013223 (2013).","journal-title":"Immunity"},{"key":"BFsrep42159_CR56","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1038\/cddis.2012.176","volume":"3","author":"N Takahashi","year":"2012","unstructured":"Takahashi, N. et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell death & disease 3, e437 (2012).","journal-title":"Cell death & disease"},{"key":"BFsrep42159_CR57","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCRESAHA.111.256529","volume":"109","author":"IT Daissormont","year":"2011","unstructured":"Daissormont, I. T. et al. Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity. Circulation research 109, 1387\u20131395 (2011).","journal-title":"Circulation research"},{"key":"BFsrep42159_CR58","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/cdd.2012.133","volume":"20","author":"A Degterev","year":"2013","unstructured":"Degterev, A., Maki, J. L. & Yuan, J. Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ 20, 366 (2013).","journal-title":"Cell Death Differ"},{"key":"BFsrep42159_CR59","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1152\/physrev.00041.2008","volume":"89","author":"JE Wagenseil","year":"2009","unstructured":"Wagenseil, J. E. & Mecham, R. P. Vascular extracellular matrix and arterial mechanics. Physiol Rev 89, 957\u2013989 (2009).","journal-title":"Physiol Rev"},{"key":"BFsrep42159_CR60","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jvs.2008.04.016","volume":"48","author":"J Xiong","year":"2008","unstructured":"Xiong, J. et al. Elastic fibers reconstructed using adenovirus-mediated expression of tropoelastin and tested in the elastase model of abdominal aortic aneurysm in rats. Journal of vascular surgery 48, 965\u2013973 (2008).","journal-title":"Journal of vascular surgery"},{"key":"BFsrep42159_CR61","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1161\/ATVBAHA.116.307784","volume":"36","author":"M Imanishi","year":"2016","unstructured":"Imanishi, M. et al. Hypoxia-Inducible Factor-1alpha in Smooth Muscle Cells Protects Against Aortic Aneurysms-Brief Report. Arterioscler Thromb Vasc Biol 36, 2158\u20132162 (2016).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFsrep42159_CR62","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1172\/JCI8931","volume":"105","author":"R Pyo","year":"2000","unstructured":"Pyo, R. et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. The Journal of Clinical Investigation 105, 1641\u20131649 (2000).","journal-title":"The Journal of Clinical Investigation"},{"key":"BFsrep42159_CR63","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1172\/JCI7818","volume":"105","author":"A Daugherty","year":"2000","unstructured":"Daugherty, A., Manning, M. W. & Cassis, L. A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105, 1605\u20131612 (2000).","journal-title":"J Clin Invest"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep42159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42159","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T01:31:11Z","timestamp":1671845471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep42159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,10]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,13]]}},"alternative-id":["BFsrep42159"],"URL":"https:\/\/doi.org\/10.1038\/srep42159","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,10]]},"assertion":[{"value":"26 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42159"}}